Precision Access Quotient

What Precision Access Quotient does

Precision Access Quotient (Precision AQ) is a privately held life sciences commercialization partner headquartered in Bethesda, Maryland, with a New York corporate office and a London international regional headquarters. The company provides consulting, agency, and data product services to global pharmaceutical manufacturers and biotech innovators across the full drug commercialization lifecycle—from HEOR evidence generation, payer strategy, and access consulting through medical communications, peer-to-peer marketing, advertising, brand strategy, investor relations, and patient communications. Precision AQ claims trusted-by status with all 30 of the world's top pharmaceutical companies and reports supporting 450+ drug launches and label expansions across therapeutic areas including oncology, immunology, neurology, rare disease, and cardio renal metabolic.

The company's technology stack centers on proprietary platforms DecodeRx and PatientLens, which power data-driven commercialization decisions, alongside the Navigator365™ suite (Core, Benchmark, Matrix) for omnichannel customer engagement, AccessGenius for market access data, OncoGenius for oncology landscape insights across U.S. cancer centers, and EHR Solutions for treatment plan integration. In November 2025, Precision AQ made a strategic investment in Phluence (formerly Lifelink Systems), an agentic AI workflow management platform designed to virtualize patient and HCP engagement with generative AI-powered conversational interfaces, expanding the company into post-prescription patient services automation. The team comprises over 1,200 experts including statisticians, PharmDs, PhDs, MDs, Board-Certified Oncology Pharmacists, and strategic consultants.

The business model operates across three revenue streams: (1) Consulting & Advisory Services (market access, HEOR, brand strategy, medical affairs, strategic advisory) billed as professional services; (2) Agency Services (medical communications, peer-to-peer marketing, advertising, branding, PR, learning & development) also as professional services; and (3) Data Solutions & Products (AccessGenius, OncoGenius, EHR Solutions, Navigator365, Phluence) structured as subscription/recurring. Pricing is quote-based and not publicly disclosed. GTM motion is enterprise field sales targeting biopharma innovators and market access leaders, with international expansion underway via the London regional hub.

Name

Precision Access Quotient

Legal name

Precision AQ

Website

https://precisionaq.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Precision Access Quotient is a privately held life sciences commercialization partner that combines consulting, agency services, and proprietary data/AI platforms to help pharmaceutical manufacturers and biotech innovators execute drug launches, market access strategy, HEOR evidence, and patient engagement across all therapeutic areas.

Ownership category

akta.pro rank

Product category

Pharmaceutical Commercialization Services

NAICS

Other Scientific and Technical Consulting Services (54169)

akta.pro primary industry

Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)

akta.pro secondary industry

Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

Keywords

• Pharmaceutical commercialization
• Market access consulting
• HEOR evidence generation
• Omnichannel engagement platforms
• Life sciences data analytics

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Consulting & Advisory Services: The company provides expert consulting services across market access, HEOR, access consulting, brand strategy, medical affairs, and strategic advisory for pharmaceutical commercialization. Services span from real-world data research to patient communications and investor relations.
2. Agency Services: Full-service agency offering including medical communications, peer-to-peer marketing, advertising, branding, PR and communications, and learning & development services for pharma and biotech clients.
3. Data Solutions & Products: Proprietary data products and solutions including AccessGenius, OncoGenius, EHR Solutions, and Data Solutions that power commercial decision-making and market intelligence.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Precision AQ is a commercialization partner for life sciences companies that helps pharmaceutical and biotech innovators turn complex data into actionable market access and brand strategies. It delivers its offering through a combination of proprietary technology platforms (AccessGenius, OncoGenius, Navigator365, DecodeRx, PatientLens, and Phluence) and professional consulting, HEOR, medical communications, and agency services across the full drug commercialization lifecycle.

Product overview

Precision AQ offers a comprehensive suite of commercialization solutions for life sciences companies, combining technology platforms, data products, and consulting services. The core product portfolio includes: AccessGenius and Data Solutions for market access intelligence; OncoGenius for oncology-specific insights; EHR Solutions for treatment plan integration; and the Navigator365 suite (Navigator365 Core, Benchmark, and Matrix) for omnichannel customer engagement. Proprietary technologies DecodeRx and PatientLens power data-driven decision-making. Through strategic investment in Phluence, Precision AQ has expanded into agentic AI-powered patient services automation, enabling pharmaceutical manufacturers to virtualize patient services with intelligent automation. The company serves all 30 of the world's top pharmaceutical companies and leading biotechs, specializing in transforming complex data into clear, actionable strategies that accelerate access to innovation.

Differentiator

Problem solved

Functional benefit

Brands

• AccessGenius: Product offering for HCP, payer, and patient engagement with products that evaluate market potential
• OncoGenius
• Navigator365
• DecodeRx
• PatientLens
• Good Patient Partnership Guide (GPPG)
• Access Made Possible

Products and services

• AccessGenius Market access data solution that helps pharmaceutical and biotech clients evaluate market potential and streamline targeting for commercial impact, powering HCP, payer, and patient engagement.
• Data Solutions Data-driven solutions providing insights for market access, payer strategy, and commercial decision-making for life sciences clients.
• EHR Solutions Electronic health record integration and solutions supporting treatment plan readiness, formulary access, and prior authorization processes for life sciences clients.
• Omnichannel Solutions Evidence-based omnichannel engagement solutions fueled by insights from the Navigator365 suite for customer engagement across multiple channels.
• OncoGenius Oncology-focused solution providing insights into provider access barriers, formularies, EHR treatment plans, and pathways across leading U.S. cancer centers, including the OncoGenius Landscape Report.
• Navigator365 Core Core platform for omnichannel customer engagement providing data-driven insights for HCP, payer, and patient engagement strategies.
• Navigator365 Benchmark Benchmarking solution for brands to evaluate omnichannel leadership positioning and customer experience performance.
• Navigator365 Matrix Solution for identifying the most influential digital opinion leaders in specific therapeutic areas and markets.
• Market Access Consulting Strategic consulting services for market access, payer strategy, and access commercialization for pharmaceutical and biotech clients.
• HEOR (Health Economics and Outcomes Research) Health economics and outcomes research services generating evidence to support market access, payer negotiations, and value demonstration for pharmaceutical products.
• Market Access Agency Services Full-service market access agency providing payer marketing, payer communications, and market access creative services for pharmaceutical clients.
• Medical Communications Medical communications services including peer-to-peer marketing, medical affairs support, and learning & development for pharmaceutical and biotech clients.
• Investor Relations & Public Relations Investor relations and public relations services supporting life sciences companies in financial communications, media relations, and corporate communications.
• Brand Strategy & Advertising Brand strategy, advertising, branding, and data-driven marketing services for pharmaceutical and biotech clients.

Quantifiable outcome

• 450+ drug launches and label expansions across all therapeutic areas
• +3 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

One partnership is on record.

• Phluence (formerly Lifelink Systems)coreStrategic or Co-development Partner · 18 November 2025Precision AQ announced a strategic investment in Phluence, an advanced agentic workflow management platform designed to virtualize patient and HCP engagement. The partnership enables pharmaceutical manufacturers to modernize patient services with scalable, data-driven solutions. By integrating best-in-class generative AI models and toolkits, Phluence enables real-time, personalized support at the point of need. The investment expands Precision AQ's post-prescription solution space, offering transformative alternatives to traditional labor-intensive HUB models through agentic triage, predictive analytics, and intelligent automation. Ashwin Athri, EVP of Strategy, Innovation and Partnerships at Precision AQ, will become incoming CEO of Phluence.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Largest global life sciences commercialization and data-services platform combining RWE/HEOR, market access consulting, technology, and clinical research — directly comparable to Precision AQ's full commercialization journey and serves the same top-30 pharma buyer base.
• Veeva Systems: Enterprise cloud software (CRM, Vault, Nitro) for life sciences with growing data and consulting offerings that overlap with Precision AQ's Navigator365, EHR Solutions, and market access data products.
• Syneos Health (now part of Ellab): Contract research and commercialization organization offering medical communications, market access, and patient engagement services to pharma manufacturers — overlapping with Precision AQ's medical affairs and brand strategy capabilities.
• Inizio (including Ashfield and Evoke): Global commercialization platform combining medical communications, patient engagement, market access, and advisory — a scaled peer to Precision AQ's medical communications and patient services business.

Direct peers

• Eversana: End-to-end pharma commercialization services partner covering market access, HEOR, patient services/HUB, medical communications, and data — most directly comparable to Precision AQ's integrated services-plus-technology model.
• Real Chemistry: Healthcare marketing, communications, and data-driven commercial agency serving pharma and biotech — directly comparable to Precision AQ's brand strategy, advertising, and omnichannel engagement services.
• Avalere Health (formerly Fishawack Health): Healthcare consulting and commercialization services firm with deep market access, HEOR, medical affairs, and omnichannel capabilities — closely aligned with Precision AQ's therapeutic-area expertise model and pharma buyer base.
• ZS Associates: Management consulting and technology firm focused on pharma sales, marketing, and data analytics — comparable to Precision AQ's data-driven market access, omnichannel, and brand strategy offerings.
• Beghou Consulting: Specialized life sciences commercialization consulting firm focused on data-driven sales, marketing, and market access analytics — closely comparable to Precision AQ's data solutions and consulting services.

Emerging players

• Definitive Healthcare: Healthcare commercial intelligence and analytics platform used by pharma for targeting, market access, and provider/payer insights — overlaps with Precision AQ's AccessGenius and Data Solutions capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xlinkedin.com/company/precision-aq
• LinkedInlinkedin.com/company/precision-aq

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Access Quotient